All Studies

Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia

Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity

Hemophagocytic lymphohistiocytosis gene variants in severe aplastic anemia and their impact on hematopoietic cell transplantation outcomes

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.

Measurable residual FLT3 internal tandem duplication before allogeneic transplant for acute myeloid leukemia.

Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-cell lymphoma after 2 or more lines of prior therapy

Pulmonary Hypertension After Pediatric Allogeneic Hematopoietic Stem Cell Transplant: Incidence, Risk Factors, and Outcomes

Critical illness risk and long-term outcomes following intensive care in pediatric hematopoietic cell transplant recipients.

DNA sequencing to detect residual disease in adults with acute myeloid leukemia prior to hematopoietic cell transplant

HLA Haplotypes and Relapse After Hematopoietic Cell Transplantation